A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(285 sites)

United States

Cahaba Dermatology & Skin Health Center /ID# 254876, Birmingham, Alabama

Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564, Fountain Hills, Arizona

Medical Dermatology Specialists /ID# 254226, Phoenix, Arizona

Mayo Clinic - Scottsdale /ID# 254388, Scottsdale, Arizona

Banner University Medicine Dermatology /ID# 255853, Tucson, Arizona